Cancer treatment is currently undergoing a significant shift with a focus on germline testing and CAR T-cell therapy. Germline testing can identify inherited gene mutations, allowing for personalized treatment plans and early detection. However, it is not fully utilized yet. CAR T-Cell therapy, using CRISPR technology, offers immense potential for treating blood cancers. Discoveries of hidden genetic factors, such as loss of the Y chromosome in bladder cancer, may also improve targeted treatments. Cancer screenings, despite associated controversies, remain essential in cancer prevention, but need balancing with overdiagnosis risks. Additionally, novel drug combinations and repurposing of existing drugs represents another vital aspect of personalized medicine in cancer treatment. With these advancements at the forefront, the future of cancer treatment shows promise.

Full article here: https://ipllfirm.com/all-insights/news-and-articles/title-redefining-cancer-treatment-the-untapped-potential-of-germline-testing-and-revolutionary-car-t-cell-therapy/